GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending. But thus far, the data don’t show this.
What to Know About Ozempic, Wegovy and the New Weight-Loss Market
Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new class of weight-loss drugs.
Will weight-loss drugs lead to upheaval in the sugar market?
The health risks of too much sugar have been made clear, but the billion-dollar global market to supply it is thriving. Sales of sweet treats remain strong, and waistlines keep expanding. Could weight-loss drugs now succeed where governments,
Could Trump Make A Big Weight Loss Drug Deal?
Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would drugmakers agree to reduce their prices right away?
Weight loss drugs seem to be driving down grocery bills
GLP-1 weight-loss drugs such as Ozempic and Wegovy are driving down grocery spending, according to a new study from Cornell’s SC Johnson College of Business and consumer data firm Numerator.
Weight loss drugs can cut grocery spending by up to 9%: study
Higher-income households with at least one user of GLP-1 class of weight loss drugs cut their grocery spending by nearly 9%, a recent study based on data from the market research firm Numerator indicates.
West Virginia patients are left in limbo over changing insurance coverage of obesity medications
While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...
FiercePharma1d
Lilly’s Zepbound expected to surpass Novo’s Wegovy to ‘dominate’ obesity market: GlobalData
Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, ...
New Scientist3d
Ozempic and Wegovy have heart health benefits beyond just weight loss
A study in pigs has shown that the active ingredient in Ozempic and Wegovy directly boosts heart health, in addition to the ...
Tirzepatide outpacing Wegovy in the obesity space
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...
Opinion
BioSpace53mOpinion
Opinion: Why Is Novo Outperforming Lilly Despite Having Inferior GLP-1 Products?
Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...
dailymemphian3d
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
The medications are so common now, two-thirds of the clinic’s calls for insurance pre-authorizations are for the big three: ...
Ozempic and Similar Drugs May Offer Health Benefits Beyond Weight Loss, Including Reduced Alcohol Cravings
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
Ozempic economics: How GLP-1s will disrupt the economy in 2025
A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...
Ozempic vs. Wegovy: What’s the Difference?
Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?
Dr. Roach: Ozempic dosage can be increased if/when a plateau is reached
Wegovy and Ozempic are the exact same drug: semaglutide. They are dosed slightly differently and marketed for different ...